Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors

出版年份 2020 全文链接

标题

作者

关键词

Type 2 diabetes mellitus, Cardiovascular risk, Glucagon-like peptide 1 receptor agonists, DPP4- inhibitors

出版物

Volume 111, Issue -, Pages 154343

出版商

Elsevier BV

发表日期

2020-08-16

DOI

10.1016/j.metabol.2020.154343

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started